OTCMKTS:FSNUY - FRESENIUS SE &/S Stock Price, Forecast & News

FRESENIUS SE &/S trades on the OTCMKTS under the ticker symbol "FSNUY."

FRESENIUS SE &/S announced an annual dividend on Monday, April 8th. Investors of record on Tuesday, May 21st will be given a dividend of $0.15 per share on Thursday, May 30th. This represents a yield of 1.03%. The ex-dividend date of this dividend is Monday, May 20th. View FRESENIUS SE &/S's Dividend History.

FRESENIUS SE &/S (OTCMKTS:FSNUY) issued its quarterly earnings data on Tuesday, October, 29th. The company reported $0.22 EPS for the quarter. The business earned $9.83 billion during the quarter. View FRESENIUS SE &/S's Earnings History.

FRESENIUS SE &/S is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for FRESENIUS SE &/S.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FRESENIUS SE &/S in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for FRESENIUS SE &/S.

Media coverage about FSNUY stock has been trending positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. FRESENIUS SE &/S earned a media sentiment score of 3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for FRESENIUS SE &/S.

Some companies that are related to FRESENIUS SE &/S include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Insulet (PODD), Novocure (NVCR), ABIOMED (ABMD), Hill-Rom (HRC), Haemonetics (HAE), Penumbra (PEN) and Globus Medical (GMED).

Based on aggregate information from My MarketBeat watchlists, some companies that other FRESENIUS SE &/S investors own include Alibaba Group (BABA), Agile Therapeutics (AGRX), Frequency Therapeutics (FREQ), Square (SQ), Aerie Pharmaceuticals (AERI), Banner (BANR), Booking (BKNG), Change Healthcare (CHNG), Chimerix (CMRX) and Cree (CREE).

Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of FSNUY stock can currently be purchased for approximately $13.46.

FRESENIUS SE &/S has a market capitalization of $29.95 billion and generates $39.40 billion in revenue each year. The company earns $2.39 billion in net income (profit) each year or $0.79 on an earnings per share basis. FRESENIUS SE &/S employs 283,795 workers across the globe.View Additional Information About FRESENIUS SE &/S.

The official website for FRESENIUS SE &/S is http://www.fresenius.com/.

FRESENIUS SE &/S's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at 49-6172-6080 or via email at [email protected]